Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Aug 29, 2021 1:37pm
88 Views
Post# 33779599

RE:Samira

RE:SamiraSamira's share count isn't an issue - never has been.
Will she likely "up" her regular purchase amount when she becomes CEO?  probably but it really doesn't matter how she plays share ownership.
Keep in mind that she is more conservative than Goodman - she sees Knight differently than Goodman.
 
Goodman is an entrepreneur and Knight is his baby.  Always will be.
He's also very controlling so share count is important to him.

She has nothing to prove on share ownership and "diversification" is likely high on her personal financial priorty list.

I would certainly take that bet ... as I see no reason to assume GUD would ever go private.  That makes as much sense as someone assuming the same thing in Goodman's first go-around.  He's already proven that his goal is to grow the business for shareholders.

Finally ... do you think I'm get paid more or less if better spelling?  I'm surely like to maximize me cash intake so if qu think I should do somting differantlie, I'd jump all over your sugeston.  It means so moch to my!

Hahaha.  Love it!

: )

<< Previous
Bullboard Posts
Next >>